CONNECT WITH US
HealthTech

HealthTech

Antimalarial drug persists in mosquitoes for days, potentially exposing developing parasites

Medical Xpress logo

Published on

Add as a preferred source on Google
Antimalarial drug persists in mosquitoes for days, potentially exposing developing parasites

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Antimalarial drugs are designed to protect people from malaria, but they may also affect the mosquitoes exposed to them during blood meals. A new Yale study, published in The Journal of Infectious Diseases, investigates the impact of these medications on mosquitoes, laying the groundwork for future research into how the drugs may influence the malaria parasites developing within them.

"I was really interested in trying to understand more about drug resistance transmission dynamics in sub-Saharan Africa," says Morgan Goheen, M.D., Ph.D., instructor (infectious diseases) at Yale School of Medicine and first author of the study. "The more we thought about it, the more it was obvious that mosquitoes must be ingesting these drugs when they feed on people who have taken them."

Malaria parasites require both humans and mosquitoes to complete their life cycle. After a mosquito feeds on an infected person, the parasites spend about 10–14 days developing inside the mosquito before they can be transmitted to another person. During that time, mosquitoes continue taking blood meals from other people. Because antimalarial drug use is widespread in malaria-endemic regions, some of those blood meals are likely to come from people taking the medications.

"We thought there was a high likelihood that infected mosquitoes are ingesting antimalarials during the time period that parasites are developing within them," Goheen says.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.